Do CJC and ipamorelin actually make you taller? We checked

What did @petatrutide actually say?

The creator's core argument is this: CJC-1295 and ipamorelin are growth hormone secretagogues that stimulate HGH and IGF-1 production, but they cannot make you taller once your growth plates have fused, which typically happens between ages 14 and 17. They also warned that teenagers who use these peptides to try to maximize height could suppress their natural GH axis and end up shorter than they would have been otherwise.

The delivery is chaotic and the language is genuinely offensive in places, but strip that away and the underlying argument is more medically coherent than most peptide content on Instagram. The creator distinguishes between the mechanism (secretagogue activity) and the effect (height gain requiring open epiphyses), which is a distinction most peptide influencers don't bother making.

Does the science back this up?

On the core claim, yes, pretty solidly. Growth plates, or epiphyseal plates, fuse under the influence of rising sex hormones during puberty, and once fused, additional growth hormone cannot stimulate longitudinal bone growth regardless of how much is circulating. This is not controversial endocrinology.

CJC-1295 is a GHRH analogue that extends the half-life of growth hormone-releasing hormone signaling. Ipamorelin is a selective ghrelin receptor agonist. Used together, they produce a synergistic pulse of GH from the pituitary. A 2006 study by Teichman et al. in the Journal of Clinical Endocrinology and Metabolism confirmed CJC-1295 significantly elevated GH and IGF-1 in healthy adults. A 2008 study by Raun et al. in the European Journal of Endocrinology showed ipamorelin's selectivity for GH release with minimal effect on cortisol or prolactin. Neither study involved adolescents, and neither claimed height benefits in subjects with fused plates.

The suppression warning, specifically that exogenous GH stimulation in adolescents could blunt natural GH axis function, is mechanistically plausible. The hypothalamic-pituitary axis operates on negative feedback loops. Chronic overstimulation can desensitize receptors. This is documented in the literature on synthetic GH therapy misuse, though data specific to secretagogue use in healthy adolescents is sparse.

What did they get wrong (or right)?

They got the big stuff right. Growth plate fusion is real, the secretagogue mechanism is described accurately enough, and the warning against adolescent use is the correct clinical position. Give credit where it's due.

Where they went wrong: the claim that growth plates fuse by "14 to 17 years old" is an oversimplification. Epiphyseal fusion varies significantly by bone site, sex, and individual. Some plates close earlier, some, particularly in the spine, can remain active into the early twenties. A 2020 review by Thivel et al. in Frontiers in Pediatrics noted high variability in skeletal maturation timing. Saying "if you made it to peptide content watching age, your skeleton is in its final form" is too broad and could be wrong for some 15 or 16-year-olds.

The creator also implies that one to two inches of gain from peptides is plausible in adolescents with open plates. That number is not cited and is speculative. Clinical GH therapy in GH-deficient children can add significant height, but the data on secretagogues specifically in GH-sufficient adolescents is essentially nonexistent. Presenting a specific inch range as a tradeoff is not supported by evidence.

What should you actually know?

CJC-1295 and ipamorelin are not approved by the FDA for height enhancement, muscle gain, or anti-aging in any population. They are research compounds. The FDA has flagged both as ineligible for compounding under the Federal Food, Drug, and Cosmetic Act as of 2024, which means legal access through regulated channels has become significantly more restricted in the United States.

If you are under 18, the answer is simple: there is no clinical evidence that these peptides will make you taller, and there is legitimate concern that interfering with your natural GH axis during puberty could have lasting hormonal consequences. The creator's advice to "let your body cook" is, beneath the noise, the right call.

Adults considering peptide therapy for recovery, sleep, or body composition should do so under physician supervision with proper lab monitoring of IGF-1 levels, since chronically elevated IGF-1 has been associated with increased cancer risk in some observational studies, including a 2012 meta-analysis by Renehan et al. in The Lancet Oncology. This is not a compound to self-dose based on Instagram content, no matter how many views the video has.